UC 112 - ≥98%(HPLC) , CAS No.383392-66-3

CAS: 383392-66-3 Cat. No.: U288560 Fórmula: C22H24N2O2 Peso molecular: 348.44 PubChem CID: 3426979
Disponible para pedir
CALIDAD & PUREZA ≥98%(HPLC)
Synonyms
5-((benzyloxy)methyl)-7-(pyrrolidin-1-ylmethyl)quinolin-8-ol | 5-[(Phenylmethoxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
5mg
U288560-5mg
1 Disponible
—
154,90US$
10mg
U288560-10mg
1 Disponible
—
216,90US$
25mg
U288560-25mg
1 Disponible
—
488,90US$
50mg
U288560-50mg
1 Disponible
—
870,90US$
100mg
U288560-100mg
1 Disponible
—
1.569,90US$
Enter a quantity for the sizes you want to add.
🧪
Por qué esta calidad

≥98%(HPLC) para flujos de trabajo cromatográficos y analíticos sensibles que requieren una interferencia mínima de la línea base.

🌡

Almacenamiento y envío

Store at -20°C Envío Ice chest + Ice pads. Consulte el COA específico del lote para conocer las especificaciones exactas.

📋

Documentos de calidad

SDS, COA, ficha técnica y hoja de especificaciones disponibles para descargar. COA específico del lote accesible mediante búsqueda por número de lote.

📚

Prueba documental

Citado en 0 publicaciones revisadas por pares sobre cromatografía, síntesis orgánica y reacciones de acoplamiento cruzado.

Especificaciones

Sinónimos
5-((benzyloxy)methyl)-7-(pyrrolidin-1-ylmethyl)quinolin-8-ol | 5-[(Phenylmethoxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol
Especificaciones y pureza
≥98%(HPLC)
Mecanismos bioquímicos y fisiológicos
IAP inhibitor (IC50values from 0.7 - 3.4μM); inhibits cell growth in multiple cancer cell lines and in a melanoma xenograft modelin vivo. Also suppresses X-linked inhibitor of apoptosis protein (XIAP) and survivin levels. Inhibits the growth of P-glycopro
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Pureza
≥98%(HPLC)
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488194394
Sonrisas canónicas
C1CCN(C1)CC2=CC(=C3C=CC=NC3=C2O)COCC4=CC=CC=C4
IUPAC Name
5-(phenylmethoxymethyl)-7-(pyrrolidin-1-ylmethyl)quinolin-8-ol
InChIKey
LTGLGIQQZXSLLF-UHFFFAOYSA-N
INCHI
1S/C22H24N2O2/c25-22-18(14-24-11-4-5-12-24)13-19(20-9-6-10-23-21(20)22)16-26-15-17-7-2-1-3-8-17/h1-3,6-10,13,25H,4-5,11-12,14-16H2
Isómeros SMILES
C1CCN(C1)CC2=CC(=C3C=CC=NC3=C2O)COCC4=CC=CC=C4
PubChem CID
3426979
Peso molecular
348.44

Documentación

📋 Hoja de datos de seguridad (SDS)

Documento completo sobre peligros, manipulación, almacenamiento y cumplimiento normativo.

<<<<<<< HEAD Descargar SDS → ======= Descargar SDS → >>>>>>> release248-p3

✅ Certificado de análisis (COA)

Datos de calidad específicos del lote. Introduzca su número de lote para obtener el COA exacto.

Buscar COA →

📊 Ficha técnica

Resumen de referencia rápida de las especificaciones y aplicaciones del producto.

Ver ficha técnica →

🔬 Hoja de especificaciones

Atributos de calidad completos y criterios de aceptación para esta calidad.

Ver hoja de especificaciones →

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClaseQuinolines and derivatives
Subclass8-hydroxyquinolines
Intermediate Tree Nodes Not available
Direct Parent8-hydroxyquinolines
Alternative Parents Benzylethers  Aralkylamines  Pyridines and derivatives  N-alkylpyrrolidines  Heteroaromatic compounds  Trialkylamines  Dialkyl ethers  Azacyclic compounds  Organopnictogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents 8-hydroxyquinoline - Benzylether - Aralkylamine - Monocyclic benzene moiety - Pyridine - Benzenoid - N-alkylpyrrolidine - Pyrrolidine - Heteroaromatic compound - Tertiary amine - Tertiary aliphatic amine - Dialkyl ether - Ether - Azacycle - Organooxygen compound - Organonitrogen compound - Amine - Organic oxygen compound - Organopnictogen compound - Hydrocarbon derivative - Organic nitrogen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as 8-hydroxyquinolines. These are compounds containing a quinoline moiety, which carries a hydroxy group at the 8-position. Quinoline consists of a benzene ring fused to a pyrimidine ring to form benzo[b]azabenzene.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
POLI Tchem DNA polymerase iota (116820 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4A Tchem Lysine-specific demethylase 4A (52245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L3MBTL1 Tchem Lethal(3)malignant brain tumor-like protein 1 (14536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4E Tchem Lysine-specific demethylase 4D-like (40243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMAD3 Tchem Mothers against decapentaplegic homolog 3 (68039 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATAD5 Tbio ATPase family AAA domain-containing protein 5 (122566 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BAZ2B Tchem Bromodomain adjacent to zinc finger domain protein 2B (56204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APOBEC3F Tbio DNA dC->dU-editing enzyme APOBEC-3F (14861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRIM24 Tchem Transcription intermediary factor 1-alpha (2087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRPF1 Tchem Peregrin (2217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TGR Thioredoxin glutathione reductase (28579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mitf Microphthalmia-associated transcription factor (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NS1 Nonstructural protein 1 (33327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP40, subfamily A, putative (505 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

11 results found

Lot NumberCertificate TypeFechaArticulo
C2625077C2625077Certificate of AnalysisApr 07, 2026 U288560
D2311231D2311231Certificate of AnalysisFeb 28, 2023 U288560
D2311235D2311235Certificate of AnalysisFeb 28, 2023 U288560
D2311236D2311236Certificate of AnalysisFeb 28, 2023 U288560
D2311255D2311255Certificate of AnalysisFeb 28, 2023 U288560
D2311273D2311273Certificate of AnalysisFeb 28, 2023 U288560
D2311274D2311274Certificate of AnalysisFeb 28, 2023 U288560
D2311284D2311284Certificate of AnalysisFeb 28, 2023 U288560
D2311285D2311285Certificate of AnalysisFeb 28, 2023 U288560
D2311288D2311288Certificate of AnalysisFeb 28, 2023 U288560
D2311391D2311391Certificate of AnalysisFeb 28, 2023 U288560
Propiedades químicas y físicas
SolubilidadSolvent:DMSO, Max Conc. mg/mL: 34.84, Max Conc. mM: 100
Peso molecular348.400 g/mol
XLogP33.300
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass348.184 Da
Monoisotopic Mass348.184 Da
Topological Polar Surface Area45.600 Ų
Heavy Atom Count26
Formal Charge0
Complexity420.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

No vendor-validated protocols are provided for this item. The following is general guidance for handling small-molecule screening compounds; adapt to your assay and treat as non-binding, research-only guidance.

General small-molecule dosing (biochemical assay)

  • Prepare a 10 mM stock in anhydrous DMSO. If insoluble, reduce to 1–5 mM and/or gently warm and sonicate. Filter if necessary using a low-binding 0.2 µm PTFE filter.
  • Perform serial dilutions in DMSO to create a range (e.g., 10-point 3-fold). Transfer to assay buffer to achieve final DMSO ≤0.5% v/v.
  • Include vehicle-only controls at matching DMSO levels and positive/negative controls as appropriate.

Cell-based assays (general)

  • Verify tolerability of the final DMSO concentration for your cell line/model. Pre-screen for cytotoxicity of vehicle and matrix effects.
  • Consider adsorption and light sensitivity; use low-binding plates and protect from light if needed.

Documentation

  • Record lot, stock concentration, preparation date, diluent, and storage. Monitor for precipitation or color change; discard if visible degradation occurs.

Item-specific, tested applications and recommended dilutions: Not specified for this item; refer to CoA/Spec Sheet.

Biological Roles

Item-specific biological target(s), pathways, or modes of action for UC 112 are not provided in the Product Data.

  • Target specificity and mechanism: Not specified for this item; consult primary literature using CAS 383392-66-3 and PubChem CID 3426979 for peer-reviewed reports of biological activity, if any.
  • Use context: In compound libraries, such molecules are commonly employed as tool compounds or for hit/lead discovery. Users should independently confirm identity, purity, and activity under their assay conditions.
  • Experimental considerations (general): Verify that the vehicle (e.g., DMSO) does not exceed the tolerance of the model system. Include orthogonal assays to confirm on-target effects and to identify nuisance behaviors (aggregation, redox cycling, covalent reactivity, fluorescence interference).
  • Documentation: Record full experimental conditions (cosolvent %, plate type, incubation times, cell density or enzyme concentration) to ensure reproducibility and facilitate cross-study comparison.

No medical or clinical claims are made; for research use only.

Buffer Applications

This product is not a buffer reagent. However, when dosing small molecules into buffered systems for assays, the buffer composition can strongly influence apparent activity and solubility.

General guidance

  • Common assay buffers: HEPES, PBS, Tris, or MOPS adjusted to the optimal pH for the biological target. Maintain consistent ionic strength and include small amounts of non-ionic surfactant (e.g., 0.01–0.05% Tween 20) if precipitation or adsorption to plastics is observed.
  • DMSO carryover: Keep final DMSO at ≤0.5% v/v for most biochemical assays and ≤0.2–0.5% v/v for cell-based assays, unless justified otherwise. Always include vehicle controls.
  • Adsorption: Hydrophobic compounds may bind to polypropylene; precondition plasticware with assay buffer containing protein or surfactant where compatible.
  • Light sensitivity: If the compound is light-sensitive (unknown here), protect plates/tubes with foil or amber plastic during incubation.

Item-specific buffer compatibility: Not specified for this item; refer to CoA/Spec Sheet and pilot tests.

Green Alternatives

Because item-specific structure and solvent compatibility are not provided, the following guidance focuses on greener handling of small-molecule screening stocks rather than replacing the compound itself.

Greener solvent practices (general)

  • Prefer ethanol or water/ethanol cosolvent systems where compatible with solubility and assay biology. Pilot assess precipitation and assay interference vs. DMSO.
  • Minimize DMSO concentration in working assays; validate functionality at the lowest feasible percentage (e.g., 0.1–0.2% v/v).
  • Use micro-aliquoting (low-dead-volume tubes/plates) to reduce freeze–thaw waste and extend usable life, lowering overall solvent usage.

Comparison table (general)

  • DMSO: excellent solvency; common in screening; higher environmental and biological burden; hygroscopic and high boiling point complicates removal.
  • Ethanol: renewable feedstock, lower toxicity; may not dissolve very hydrophobic compounds; volatile and flammable.
  • PEG400/water: useful for some hydrophobes; viscous; assay-dependent compatibility.

Operational improvements

  • Implement plate sealing with low-permeation films to reduce DMSO evaporation and concentration drift.
  • Consider automation with acoustic dispensing to minimize solvent volumes and plastic waste.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation-specific information is provided for this item. This product is sold strictly for research use only.

General context

  • Screening and discovery: Such compounds are typically used in early-stage discovery research, assay development, or as reference comparators in non-clinical studies.
  • If formulation studies are conducted for research, standard preformulation assessments (solubility across pH, chemical stability in aqueous media, light/oxidative stability) should be performed. Clearly label all findings as research-only and non-clinical.

Item-specific pharmaceutical information: Not specified for this item; refer to CoA/Spec Sheet and primary literature.

Physical Properties

Item-specific physico-chemical specifications were not provided in the Product Data.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

General characterization guidance (literature/computed)

  • For small-molecule screening compounds, initial dissolution is commonly attempted in anhydrous DMSO at 10–50 mM; aqueous compatibility is then evaluated by serial dilution into assay buffer while monitoring for precipitation.
  • If the structure is retrieved via the provided CAS/CID, computed properties (cLogP, TPSA, HBD/HBA counts) from cheminformatics tools can inform expected solubility and permeability. Clearly label such values as calculated/literature and do not treat them as product specifications.
  • When preparing solutions, note and record any visible turbidity or oiling out during dilution; document final cosolvent percentage used in assays.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet for assay purity, residual solvent profile, and analytical data.

How to interpret typical documentation (general guidance)

  • Analytical characterization for screening compounds commonly includes LC–MS purity (area % at a defined UV wavelength), 1H NMR identity, and, where relevant, HRMS. Some vendors provide HPLC chromatograms across multiple wavelengths to assess UV cleanliness for bioassays and plate-based readouts.
  • If stabilizers, salt forms, or polymorph information apply, they should appear on the CoA. Absence of such notes generally implies a neat free base/neutral form, but verify against documentation before use.
  • For assay-critical work (biochemical or cellular), consider performing in-house verification: orthogonal LC–MS purity check, NMR spot check, and a quick solubility/precipitation screen in the intended assay buffer at working concentrations.

Lot-to-lot considerations

  • Record lot number and replicate key pilot data when changing lots. If solubility is marginal, minor differences in form (hydrate/solvate) may affect handling; confirm against CoA notes.
Reaction and Applications

This product is categorized under a small-molecule/compound library and is generally used as a reference or screening compound rather than as a synthetic reagent.

  • Research use: For in vitro research and assay development only (per Research Use Note). No medical or clinical use is implied.
  • Typical applications (general): biochemical target screening, phenotypic screening, mechanistic probes in cell-free assays, and control experiments in method development. Specific mechanisms/targets are not provided for this item; consult literature via CAS 383392-66-3 or CID 3426979 for peer-reviewed application reports.
  • Practical tips: prepare a DMSO master stock, verify solubility at working concentrations, include vehicle controls matched to the final DMSO percentage, and monitor precipitation by light scattering or visual inspection during assay setup.
  • Documentation: record batch/lot, stock concentration, preparation date, diluent, and storage conditions on all aliquots. Archive any vendor-supplied analytical data alongside in-house verification results.

Not typically applicable

  • Named synthetic reactions, catalysts, or reagent roles are not typically relevant for library screening compounds unless the user intends to derivatize the scaffold; in that case, consult structural data first.
Reaction Conditions

Not typically applicable. UC 112 is provided as a screening/library compound and not as a reagent for chemical synthesis. No item-specific reaction conditions are provided.

General advice (only if user intends chemical transformations)

  • Solvents and temperatures should be selected based on the actual structure and functional groups retrieved via CAS 383392-66-3 or CID 3426979.
  • Begin with small-scale scouting experiments and monitor by LC–MS to assess stability and conversion. Protect from moisture/oxygen/light as indicated by functional group sensitivity.

For most users, see the sections on Solvent Selection and Storage & Reconstitution, which are the most relevant for handling in biological assays.

Safety and Handling

Hazard communication specific to this item was not provided. Always consult the product SDS for authoritative information.

  • GHS classification, pictograms, signal word, and H-statements: Not specified for this item; refer to SDS.
  • General lab PPE: lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Work in a chemical fume hood to avoid inhalation exposure to dust/aerosols or solvent vapors.
  • Storage: Store at -20°C (per Product Data). Maintain desiccation and protect from light if the compound is light- or moisture-sensitive (verify via SDS/CoA). Keep container tightly closed.
  • Handling: Allow container to equilibrate to room temperature before opening to minimize moisture condensation. When making DMSO stocks, avoid repeated freeze–thaw cycles; aliquot as needed.
  • Incompatibilities: Without structure, specific incompatibilities cannot be stated; as a precaution avoid strong oxidizers and acids/bases until compatibility is confirmed from SDS.
  • First aid (general): In case of skin/eye contact, rinse with water for at least 15 minutes. If inhaled, move to fresh air. If swallowed, rinse mouth and seek medical advice. Provide SDS to medical personnel.
  • Waste: Dispose according to institutional chemical waste procedures; classify based on actual solvent/assay matrix used.
Solvent Selection

Item-specific solubility data are not provided. The following is general best practice for small-molecule screening compounds.

  • Primary dissolution: Start with anhydrous DMSO (analytical/anhydrous grade). Typical master stocks: 10 mM to 50 mM. If limited solubility is observed, gentle warming (≤40°C) and brief sonication can help; avoid prolonged heating.
  • Aqueous use: Dilute DMSO stocks into assay buffers with vigorous mixing to final DMSO ≤0.1–0.5% (biochemical) or ≤0.1–0.5% (cellular) unless assay tolerance allows higher; confirm tolerance empirically.
  • Alternative solvents (general): DMF or ethanol can be considered for primary dissolution if DMSO fails, followed by dilution into buffer with surfactant (e.g., 0.01–0.05% Tween 20) where compatible.
  • Polarity profile: Not specified for this item; consult literature properties (cLogP, TPSA) via the provided CAS/CID to predict solvent compatibility.

Comparison (general)

  • DMSO: highest success rate for initial dissolution; hygroscopic, can affect biological readouts at >1% v/v.
  • Ethanol: greener and volatile; lower solvating power for very lipophilic compounds; higher cell toxicity above ~1–2%.
  • DMF: strong solvent; less preferred biologically; use sparingly and ensure compatibility.
Storage and Reconstitution
  • Storage (as supplied): Store at -20°C (per Product Data). Keep tightly closed, preferably under inert atmosphere or with desiccant if moisture-sensitive. Protect from light if indicated by SDS/CoA.
  • Shipping: Shipped in an ice chest with ice pads (per Product Data). Inspect upon receipt; if warmed, re-equilibrate to -20°C promptly.
  • Reconstitution: Item-specific solvent is not provided. General practice for small molecules is to dissolve in anhydrous DMSO to prepare a concentrated stock (e.g., 10–50 mM), then aliquot and store at -20°C to avoid repeated freeze–thaw.
  • Working solutions: Prepare fresh on the day of use. Avoid prolonged storage in aqueous buffers unless stability is established. Document final cosolvent percentage.
  • Stability: Not specified for this item; refer to CoA/Spec Sheet. If no data are available, perform a small stability pilot (freeze–thaw tolerance, short-term bench stability, and light exposure) using LC–MS.
  • Research use: For research use only. Not for human or veterinary use.
Structure and Identity

Overview for SKU U288560 (UC 112). The structural identity details for this catalog item are limited in the provided Product Data; consult the CoA/Spec Sheet and primary literature for definitive structural information.

  • CAS: 383392-66-3 (as provided)
  • PubChem CID: 3426979 (as provided)
  • InChIKey: 208546 (as provided)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Item-specific functional groups, ring systems, and stereochemistry: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature)

  • The CAS and CID listed can be used to retrieve the exact 2D/3D structure, functional groups, and stereochemical descriptors from public databases (e.g., PubChem) and to verify identity against analytical data (1H/13C NMR, HRMS, LC–MS).
  • For internal documentation, include: compound code (UC 112), CAS, CID, batch/lot, and any analytical spectra received with the shipment to ensure traceable identity.
Synthetic Utility

This item is offered as a small-molecule screening compound rather than a synthetic reagent or building block.

  • Functional group reactivity, protecting group strategies, and named reaction participation cannot be detailed without structural information. If derivatization or SAR exploration is intended, obtain the full structure via the provided CAS/CID and plan routes accordingly.
  • For synthetic modifications (general): verify compound stability to common conditions (acid/base, oxidation/reduction) and confirm that the purchased lot is the desired form (free base, salt, or specific polymorph) before attempting transformations.

Item-specific synthetic roles: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Target, pathway, and species selectivity information are not provided for this item.

  • Item-specific target(s): Not specified for this item; refer to CoA/Spec Sheet and peer-reviewed literature based on CAS 383392-66-3 or CID 3426979.
  • Cross-reactivity, off-targets, and potency metrics (IC50, Ki, EC50): Not specified for this item; must be derived from independent studies and are not product specifications.

For research use only; no medical or diagnostic claims are made.

Preguntas frecuentes

What is the purity of this product, and how is it determined?
This product is supplied at ≥98% purity, determined by HPLC. Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 383392-66-3, the molecular formula is C??H??N?O?, and the molecular weight is 348.44 g/mol. InChIKey LTGLGIQQZXSLLF-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.